Cross-Platform Validation of Neurotransmitter Release Impairments in Schizophrenia Patient-Derived NRXN1-Mutant Neurons
ChangHui Pak, Tamás Dankó, Vincent R. Mirabella, Jinzhao Wang, Yingfei Liu, Madhuri Vangipuram, Sarah D. Grieder, Xianglong Zhang, Thomas Ward, Yu‐Wen Alvin Huang, Kang Jin, Phillip J. Dexheimer, Eric E. Bardes, Alexis Mitelpunkt, Junyi Ma, , Thomas Christian Südhof
This study validates that heterozygous NRXN1 deletions impair neurotransmitter release in human neurons across multiple labs, suggesting a human-specific synaptic dysfunction relevant for schizophrenia drug discovery.
Proceedings of the National Academy of Sciences · May 25, 2021Peer-reviewedNeuroscience